Dietmar Berger

GILD

Dietmar Berger serves as Chief Medical Officer at Gilead Sciences, Inc. (GILD). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

1 trades

$844.4K

Net Position

Net Seller

$844.4K

Companies Traded

GILD

Active Period

Jan 2026

1 total trades

Most Recent

Sell GILD

Jan 5, 2026 · $844.4K

Dietmar Berger's Insider Trading at Gilead Sciences, Inc. (GILD)

Buys

0 · $0.00

Sells

1 · $844.4K

Total Shares Bought

Total Shares Sold

6,944

GILD Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Jan 5, 2026↗	Sell	6,944	$121.60	$844.4K	0

Related Insiders

Daniel Patrick O'Day

director, officer: Chairman & CEO

GILDSell · Feb 27, 2026

Johanna Mercier

officer: Chief Comm & Corp Aff Officer

GILDSell · Feb 17, 2026

Andrew D Dickinson

Chief Financial Officer

GILDSell · Feb 17, 2026

Andrew D Dickinson

officer: Chief Financial Officer

GILDSell · Feb 17, 2026

Johanna Mercier

Chief Comm & Corp Aff Officer

GILDSell · Feb 17, 2026

Daniel Patrick O'Day

Chairman & CEO

GILDSell · Jan 28, 2026

Jeffrey Bluestone

director

GILDSell · Jan 20, 2026

Jeffrey Bluestone

Director

GILDSell · Jan 20, 2026

Explore More Insider Trading Data

GILD Insider Trading Activity

View all insider trades at Gilead Sciences, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity